Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects

Next Previous
Trial Profile

Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Nov 2013

At a glance

  • Drugs Guselkumab (Primary)
  • Indications Palmoplantar pustulosis; Plaque psoriasis; Rheumatoid arthritis
  • Focus Pharmacokinetics

    • Most Recent Events

    • 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 05 Jun 2013 New trial record
    • 01 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top